Shidong Jia, a highly accomplished scientist entrepreneur, is a leading figure in advancing precision medicine initiatives worldwide. With a deep-seated commitment to empowering the global healthcare ecosystem through innovation, his interests lie in liquid biopsy, clinical trials, drug development, cancer screening, precision medicine, big data, and biomarker research.

Jia honed his skills by studying at several prestigious institutions, such as Dana-Farber Cancer Institute, Harvard Medical School, Peking Union Medical College, and Harbin Medical University. His contributions and expertise extend to numerous high-profile positions, including Founder & Global CEO at Predicine, Editor-in-Chief at Journal of Circulating Biomarkers, Scientist, Biomarker Team Lead at Genentech, and Laboratory Head at Novartis.

Without a doubt, Jia's entrepreneurial and leadership talents and vast experience in advanced healthcare and biotech applications make him a highly sought-after industry figure.